Barclays lowers Gilead Sciences (NASDAQ:GILD) price target from $81 to $80

By / / Barclays, Gilead Sciences

Barclays analyst Carter Gould maintains Gilead Sciences (NASDAQ:GILD) with a Equal-Weight and lowers the price target from $81 to $80.

Scroll to Top